학술논문

Who's Not Protected in the Herd? Factors Associated with Vaccine-Type HPV in Unvaccinated Women
Document Type
article
Source
Journal of Pediatric and Adolescent Gynecology. 31(2)
Subject
Biomedical and Clinical Sciences
Clinical Sciences
Clinical Trials and Supportive Activities
Prevention
Cancer
Sexually Transmitted Infections
Immunization
HPV and/or Cervical Cancer Vaccines
Infectious Diseases
Clinical Research
HIV/AIDS
Vaccine Related
Cervical Cancer
Prevention of disease and conditions
and promotion of well-being
3.4 Vaccines
Infection
Good Health and Well Being
Adolescent
Adult
Cross-Sectional Studies
Female
Humans
Logistic Models
Papillomavirus Infections
Papillomavirus Vaccines
Prevalence
Racial Groups
Risk Factors
Sexual Behavior
Sexually Transmitted Diseases
Young Adult
Human papillomavirus
Herd protection
Vaccine
Women
Paediatrics and Reproductive Medicine
Obstetrics & Reproductive Medicine
Paediatrics
Reproductive medicine
Language
Abstract
Study objectiveEvidence suggests that vaccine-type human papillomavirus (HPV) prevalence may decrease in unvaccinated women after HPV vaccine introduction, indicating herd protection. The aim of this study was to determine factors associated with vaccine-type HPV (i.e. absence of herd protection) after vaccine introduction.DesignWe conducted three cross-sectional studies from 2006-2014 (n = 1180): wave 1 (2006-2007), wave 2 (2009-2010), and wave 3 (2013-2014).SettingParticipants were recruited from a hospital-based teen health center and a community health department.ParticipantsWe recruited 13-26 year-old young women; those included in this analysis had not received an HPV vaccine.Interventions and main outcome measuresThe outcome measure was infection with at least one vaccine-type HPV (HPV6, 11, 16, 18).ResultsMultivariable logistic regression demonstrated that in wave 1 (before vaccine introduction), history of anal intercourse (OR = 1.8, 95% CI = 1.1-3.0), age 18-21 vs 13-17 years (OR = 2.1, CI = 1.2-3.6), and Black/multiracial vs White race (OR = 1.8, CI = 1.1-3.0) were associated with vaccine-type HPV in unvaccinated women. In wave 2, no variables were associated with HPV. In wave 3, sexually transmitted infection history (OR = 3.6, CI = 1.3-9.7) was associated with HPV.ConclusionWe did not identify a consistent set of modifiable risk factors associated with vaccine-type HPV after vaccine introduction across the three study waves, underscoring the urgency of vaccination for primary HPV prevention and the limitations of relying on herd protection.